{"id":902479,"date":"2025-10-29T18:28:02","date_gmt":"2025-10-29T22:28:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/"},"modified":"2025-10-29T18:28:02","modified_gmt":"2025-10-29T22:28:02","slug":"spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/","title":{"rendered":"Spyre Therapeutics to Participate in Upcoming November Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WALTHAM, Mass., Oct.  29, 2025  (GLOBE NEWSWIRE) &#8212; Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences:<\/p>\n<p>\n        <strong>Event: Guggenheim 2<\/strong><br \/>\n        <sup><br \/>\n          <strong>nd<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Healthcare Innovation Conference &#8211; Boston<\/strong><br \/>\n        <br \/>\n        <strong>Date: <\/strong>Monday, November 10, 2025<br \/><strong>Fireside Time: <\/strong>10:00 am ET<\/p>\n<p>\n        <strong>Event: Stifel 2025 Healthcare Conference \u2013 New York<\/strong><br \/>\n        <br \/>\n        <strong>Date: <\/strong>Tuesday, November 11, 2025<br \/><strong>Fireside Time: <\/strong>8:40 am ET<\/p>\n<p>\n        <strong>Event: Jefferies Global Healthcare Conference &#8211; London<\/strong><br \/>\n        <br \/>\n        <strong>Date: <\/strong>Wednesday, November 19, 2025<br \/><strong>Fireside Time: <\/strong>8:00 am GMT<\/p>\n<p>Live audio webcasts and replays of these events will be available on the Spyre investor events website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cs3cwr1l8TO6g7Tg5oRH8R4FC0QH5rwYPPmJxmkU9torxWfJzKy-Gr73111B2-j7lGNdpWAp-kkkjnVDFLo-cFr0F5y-cEE5n7PBiU0Ec8_m7qrZCYjqAzrJAsIcXb_JiJxnm-h8DJHbSvGZPxPvIPo7K8JEgACpF5-Jvx0UIZc=\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.spyre.com\/events-and-presentations<\/a>.<\/p>\n<p>\n        <strong>About Spyre Therapeutics<\/strong>\n      <\/p>\n<p>Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases. Spyre&#8217;s pipeline includes investigational extended half-life antibodies targeting \u03b14\u03b27, TL1A, and IL-23.<\/p>\n<p>For more information, visit Spyre&#8217;s website at www.spyre.com.<\/p>\n<p>\n        <strong>For Investors:<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/>Eric McIntyre, Spyre Therapeutics<br \/>VP of Finance and Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2CgSPNDpeghYRNbm1GQsq0WSxTK4Yzz4E9E0AG0JZLZjcp3ykSnYjfRkJ1QZvF1BPXIdm4W_Lsi6-69RlYHW6TbzdFV-aTrrGeeORDajdNc=\" rel=\"nofollow\" target=\"_blank\">Eric.mcintyre@spyre.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWJhNDQxYzctZDVjMi00YTBlLTkyZjktMjVlOWNhMzg4MjE3LTEzMDYzNjMtMjAyNS0xMC0yOS1lbg==\/tiny\/Spyre-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) &#8212; Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: Event: Guggenheim 2 nd Annual Healthcare Innovation Conference &#8211; Boston Date: Monday, November 10, 2025Fireside Time: 10:00 am ET Event: Stifel 2025 Healthcare Conference \u2013 New York Date: Tuesday, November 11, 2025Fireside Time: 8:40 am ET Event: Jefferies Global Healthcare Conference &#8211; London Date: Wednesday, November 19, 2025Fireside Time: 8:00 am GMT Live audio webcasts and replays of these events will be available on the Spyre investor events website at https:\/\/ir.spyre.com\/events-and-presentations. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Spyre Therapeutics to Participate in Upcoming November Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-902479","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Spyre Therapeutics to Participate in Upcoming November Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spyre Therapeutics to Participate in Upcoming November Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) &#8212; Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: Event: Guggenheim 2 nd Annual Healthcare Innovation Conference &#8211; Boston Date: Monday, November 10, 2025Fireside Time: 10:00 am ET Event: Stifel 2025 Healthcare Conference \u2013 New York Date: Tuesday, November 11, 2025Fireside Time: 8:40 am ET Event: Jefferies Global Healthcare Conference &#8211; London Date: Wednesday, November 19, 2025Fireside Time: 8:00 am GMT Live audio webcasts and replays of these events will be available on the Spyre investor events website at https:\/\/ir.spyre.com\/events-and-presentations. &hellip; Continue reading &quot;Spyre Therapeutics to Participate in Upcoming November Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-29T22:28:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Spyre Therapeutics to Participate in Upcoming November Investor Conferences\",\"datePublished\":\"2025-10-29T22:28:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/\"},\"wordCount\":189,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/\",\"name\":\"Spyre Therapeutics to Participate in Upcoming November Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=\",\"datePublished\":\"2025-10-29T22:28:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spyre Therapeutics to Participate in Upcoming November Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spyre Therapeutics to Participate in Upcoming November Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Spyre Therapeutics to Participate in Upcoming November Investor Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) &#8212; Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (\u201cIBD\u201d) and rheumatic diseases, today announced that management will participate in the following upcoming investor conferences: Event: Guggenheim 2 nd Annual Healthcare Innovation Conference &#8211; Boston Date: Monday, November 10, 2025Fireside Time: 10:00 am ET Event: Stifel 2025 Healthcare Conference \u2013 New York Date: Tuesday, November 11, 2025Fireside Time: 8:40 am ET Event: Jefferies Global Healthcare Conference &#8211; London Date: Wednesday, November 19, 2025Fireside Time: 8:00 am GMT Live audio webcasts and replays of these events will be available on the Spyre investor events website at https:\/\/ir.spyre.com\/events-and-presentations. &hellip; Continue reading \"Spyre Therapeutics to Participate in Upcoming November Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-29T22:28:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Spyre Therapeutics to Participate in Upcoming November Investor Conferences","datePublished":"2025-10-29T22:28:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/"},"wordCount":189,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/","name":"Spyre Therapeutics to Participate in Upcoming November Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=","datePublished":"2025-10-29T22:28:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2Mjc5MCM3MjI2OTgxIzIyOTQ4MTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/spyre-therapeutics-to-participate-in-upcoming-november-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Spyre Therapeutics to Participate in Upcoming November Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/902479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=902479"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/902479\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=902479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=902479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=902479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}